NEW YORK, Feb 26 (Reuters) - Eli Lilly and Co. said on Monday that the U.S. Food and Drug Administration has added treatment of generalized anxiety disorder to the approved uses for the drugmaker's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results